Top-News

BioTime News

Aktie
WKN:  905313 ISIN:  US09066L1052
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
51,73 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 26.07.2021

BioTime News

15.09.21 - PR Newswire
Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts
Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts PR Newswire
30.01.19 - PR Newswire
Thinking about buying stock in Aurora Cannabis Inc., Advanced Micro Devices, Biotime Inc., Oncocyte Corp. or PG&E Corp.?
Thinking about buying stock in Aurora Cannabis Inc., Advanced Micro Devices, Biotime Inc., Oncocyte Corp. or PG&E Corp.? PR Newswire
26.06.17 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioTime, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioTime, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
17.12.15 - PR Newswire
Stephen C. Farrell Appointed to STAAR Surgical Board of Directors
Stephen C. Farrell Appointed to STAAR Surgical Board of Directors Company Also Reports Adoption of Governance Changes PR Newswire
27.08.14 - PR Newswire
Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury
Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury Dose Escalation ...
25.08.14 - PR Newswire
Asterias Biotherapeutics Announces Investor Briefing Conference Call and Webcast
Asterias Biotherapeutics Announces Investor Briefing Conference Call and Webcast - Wednesday, August 27, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT - PR Newswire
21.08.14 - PR Newswire
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution - Welcomes New Shareholders Who Received ...
24.07.14 - PR Newswire
Asterias Biotherapeutics Announces Live Investor Webcast
Asterias Biotherapeutics Announces Live Investor Webcast - Tuesday, July 29, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT - PR Newswire
08.08.13 - PR Newswire
PDL BioPharma Announces Second Quarter 2013 Financial Results
PDL BioPharma Announces Second Quarter 2013 Financial Results PR Newswire
30.04.13 - PR Newswire
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer PR Newswire
12.11.12 - PR Newswire
Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc.
Hadasit Bio-​Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc. BioTime to provide $3.5 million in stock to Cell Cure to ...
19.12.11 - Aktiencheck
BioTime "strong buy" - WBB Securities
Die Analysten von WBB Securities stufen die Aktie von BioTime von "buy" auf "strong buy" hoch. Das Kursziel sehe man bei 8,00 USD. (Analyse vom 19.12.2011) (19.12.2011/ac/a/a)
04.06.02 - Aktiencheck
Biotime spekulativ kaufen - INSIDER TRADING
18.12.00 - Aktiencheck
BioTime fulminante Rallye - Bluebull

Newssuche

Videos

newspaper
06.05.24 +6,89%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »